Defining bloodstream infections related to central venous catheters in patients with cancer: A systematic review

Clinical Infectious Diseases

Volumn 53, Issue 7, 2011, Pages 697-710

  Tomlinson, Deborah ^a   Mermel, Leonard A ^b,c   Ethier, Marie Chantal ^a   Matlow, Anne ^a   Gillmeister, Biljana ^a   Sung, Lillian ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; NEOPLASM; PRIORITY JOURNAL; PUBLISHING; REVIEW; SYSTEMATIC REVIEW;

CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; HUMANS; NEOPLASMS; SEPSIS; TERMINOLOGY AS TOPIC;

EID: 80052441230     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir523     Document Type: Review

References (218)

1. de Jonge RC, Polderman KH, Gemke RJ. Central venous catheter use in the pediatric patient: mechanical and infectious complications. Pediatr Crit Care Med 2005; 6:329-39. (Pubitemid 40724286)
2. Division of Nosocomial and Occupational Infectious Diseases, Bureau of Infectious Diseases, Laboratory Centre for Disease Control, Health Canada. Preventing infections associated with indwelling intravascular access devices. Can Commun Dis Rep 1997; 23(Suppl 8):Si-iii, 1-32, i-iv, 1-16.
3. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-85.
4. Boersma RS, Schouten HC. Clinical practices concerning central venous catheters in haematological patients. Eur J Oncol Nurs 2010; 14:200-4.
5. Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: a prospective, matched analysis. Am J Infect Control 2003; 31: 475-80. (Pubitemid 37533216)
6. Worth LJ, Brett J, Bull AL, McBryde ES, Russo PL, Richards MJ. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals. Am J Infect Control 2009; 37:643-8.
7. Boersma RS, Jie KS, Verbon A, van Pampus EC, Schouten HC. Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol 2008; 19: 433-42. (Pubitemid 351325662)
8. Dettenkofer M, Ebner W, Bertz H, et al. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant 2003; 31:795-801. (Pubitemid 36656672)
9. Salzman MB, Rubin LG. Intravenous catheter-related infections. Adv Pediatr Infect Dis 1995; 10:337-68.
10. Hiemenz J, Skelton J, Pizzo PA. Perspective on the management of catheter-related infections in cancer patients. Pediatr Infect Dis 1986; 5:6-11. (Pubitemid 16155252)
11. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45.
12. Pearson ML, Hierholzer WJ Jr, Garner JS, et al. Guideline for prevention of intravascular device-related infections. Am J Infect Control 1996; 24:262-93. (Pubitemid 26330729)
13. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011; 39(Suppl 1):S1-34.
14. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992; 15:197-208.
15. Mermel LA. Defining intravascular catheter-related infections: a plea for uniformity. Nutrition 1997; 13(Suppl 4):2S-4S.
16. Capdevila JA, Planes AM, Palomar M, et al. Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur J Clin Microbiol Infect Dis 1992; 11:403-7.
17. Fatkenheuer G, Buchheidt D, Cornely OA, et al. Central venous catheter (CVC)-related infections in neutropenic patients-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003; 82(Suppl 2):S149-57. (Pubitemid 37265302)
18. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52:e56-93.
19. Flynn PM. Diagnosis and management of central venous catheterrelated bloodstream infections in pediatric patients. Pediatr Infect Dis J 2009; 28:1016-7.
20. Worth LJ, Slavin MA, Brown GV, Black J. Catheter-related bloodstream infections in hematology: time for standardized surveillance? Cancer 2007; 109:1215-26. (Pubitemid 46466547)
21. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. AmJ Infect Control 1988; 16:128-40.
22. Pearson ML. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996; 17:438-73.
23. Chang L, Tsai JS, Huang SJ, Shih CC. Evaluation of infectious complications of the implantable venous access system in a general oncologic population. Am J Infect Control 2003; 31:34-9. (Pubitemid 36216573)
24. Chelliah A, Heydon KH, Zaoutis TE, et al. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Pediatr Infect Dis J 2007; 26:816-20. (Pubitemid 47329853)
25. Ishizuka M, Nagata H, Takagi K, Kubota K. Total parenteral nutrition is a major risk factor for central venous catheter-related bloodstream infection in colorectal cancer patients receiving postoperative chemotherapy. Eur Surg Res 2008; 41:341-5.
26. Simon A, Fleischhack G, Hasan C, Bode U, Engelhart S, Kramer MH. Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infect Control Hosp Epidemiol 2000; 21:592-6.
27. Simon A, Fleischhack G, Wiszniewsky G, Hasan C, Bode U, Kramer MH. Influence of prolonged use of intravenous administration sets in paediatric cancer patients on CVAD-related bloodstream infection rates and hospital resources. Infection 2006; 34:258-63. (Pubitemid 44563983)
28. Simon A, Ammann RA, Wiszniewsky G, Bode U, Fleischhack G, Besuden MM. Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. BMC Infect Dis 2008; 8:102.
29. Keung YK, Watkins K, Chen SC, Groshen S, Levine AM, Douer D. Increased incidence of central venous catheter-related infections in bone marrow transplant patients. Am J Clin Oncol 1995; 18:469-74. (Pubitemid 26004051)
30. Keung YK, Watkins K, Chen SC, Groshen S, Silberman H, Douer D. Comparative study of infectious complications of different types of chronic central venous access devices. Cancer 1994; 73:2832-7. (Pubitemid 24166273)
31. Abedin S, Kapoor G. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer. Pediatr Blood Cancer 2008; 51:251-5. (Pubitemid 351874421)
32. Adler A, Yaniv I, Solter E, et al. Catheter-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 2006; 28:23-8. (Pubitemid 43361614)
33. Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematologyoncology patients. J Hosp Infect 2006; 62:358-65. (Pubitemid 43192330)
34. Allen RC, Holdsworth MT, Johnson CA, et al. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 2008; 51:53-8. (Pubitemid 351720869)
35. Boswald M, Lugauer S, Regenfus A, et al. Reduced rates of catheterassociated infection by use of a new silver-impregnated central venous catheter. Infection 1999; 27(Suppl 1):S56-60. (Pubitemid 29255579)
36. Chaberny IF, Ruseva E, Sohr D, et al. Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies. Ann Hematol 2009; 88:907-12.
37. Horvath B, Norville R, Lee D, Hyde A, Gregurich M, Hockenberry M. Reducing central venous catheter-related bloodstream infections in children with cancer. Oncol Nurs Forum 2009; 36:232-8.
38. Moller T, Borregaard N, Tvede M, Adamsen L. Patient education-a strategy for prevention of infections caused by permanent central venous catheters in patients with haematological malignancies: a randomized clinical trial. J Hosp Infect 2005; 61:330-41. (Pubitemid 43009078)
39. Shah SS, Manning ML, Leahy E, Magnusson M, Rheingold SR, Bell LM. Central venous catheter-associated bloodstream infections in pediatric oncology home care. Infect Control Hosp Epidemiol 2002; 23:99-101. (Pubitemid 34205643)
40. Worth LJ, Seymour JF, Slavin MA. Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices. Support Care Cancer 2009; 17:811-8.
41. Worth LJ, Black J, Seymour JF, Thursky KA, Slavin MA. Surveillance for catheter-associated bloodstream infection in hematology units: quantifying the characteristics of a practical case definition. Infect Control Hosp Epidemiol 2008; 29:358-60. (Pubitemid 351416987)
42. Yoshida J, Ishimaru T, Kikuchi T, et al. Central line-associated bloodstream infection: is the hospital epidemiology of methicillin-resistant Staphylococcus aureus relevant? J Infect Chemother 2010; 16:33-7.
43. Luft D, Schmoor C, Wilson C, et al. Central venous catheterassociated bloodstream infection and colonisation of insertion site and catheter tip: what are the rates and risk factors in haematology patients? Ann Hematol 2010; 89:1265-75.
44. Hung MC, Chen CJ, Wu KG, Hung GY, Lin YJ, Tang RB. Subcutaneously implanted central venous access device infection in pediatric patients with cancer. J Microbiol Immunol Infect 2009; 42:166-71.
45. Kaufman LJ, Clark TW, Roberts DA, et al. Do simultaneous bilateral tunneled infusion catheters in patients undergoing bone marrow transplantation increase catheter-related complications? J Vasc Interv Radiol 2004; 15:57-61. (Pubitemid 38113844)
46. Ruschulte H, Franke M, Gastmeier P, et al. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann Hematol 2009; 88:267-72.
47. Stamou SC, Maltezou HC, Pourtsidis A, Psaltopoulou T, Skondras C, Aivazoglou T. Hickman-Broviac catheter-related infections in children with malignancies. Mt Sinai J Med 1999; 66:320-6.
48. Raad I, Hanna H, Boktour M, et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 2004; 38:1119-27. (Pubitemid 38951258)
49. Abi-Said D, Raad I, Umphrey J, et al. Infusion therapy team and dressing changes of central venous catheters. Infect Control Hosp Epidemiol 1999; 20:101-5.
50. Chambers ST, Sanders J, Patton WN, et al. Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective randomized controlled trial. J Hosp Infect 2005; 61:53-61. (Pubitemid 41070274)
51. Karthaus M, Doellmann T, Klimasch T, Krauter J, Heil G, Ganser A. Central venous catheter infections in patients with acute leukemia. Chemotherapy 2002; 48:154-7.
52. Nosari A, Nichelatti M, De Gasperi A, et al. Incidence of sepsis in central venous catheter-bearing patients with hematologic malignancies: preliminary results. J Vasc Access 2004; 5:168-73. (Pubitemid 41158316)
53. Yucel N, Lefering R, Maegele M, et al. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial. J Antimicrob Chemother 2004; 54:1109-15. (Pubitemid 40136750)
54. Velasco M, Rovira M, Mensa J, Almela M, Carreras E. Utility of daily catheter-drawn blood cultures to predict catheter-related bacteremia in hematopoietic stem cell transplanted patients. Turkish J Hematol 2009; 26:67-71.
55. Pasqualotto AC, de Moraes AB, Zanini RR, Severo LC. Analysis of independent risk factors for death among pediatric patients with candidemia and a central venous catheter in place. Infect Control Hosp Epidemiol 2007; 28:799-804. (Pubitemid 47055918)
56. Gebauer B, Teichgraber UM, Werk M, Beck A, Wagner HJ. Sonographically guided venous puncture and fluoroscopically guided placement of tunneled, large-bore central venous catheters for bone marrow transplantation-High success rates and low complication rates. Support Care Cancer 2008; 16:897-904.
57. Liu CY, Huang LJ, Wang WS, et al. Candidemia in cancer patients: impact of early removal of non-tunneled central venous catheters on outcome. J Infect 2009; 58:154-60.
58. Rotstein C, Brock L, Roberts RS. The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients. Infect Control Hosp Epidemiol 1995; 16:451-8.
59. Ruggiero A, Barone G, Margani G, Nanni L, Pittiruti M, Riccardi R. Groshong catheter-related complications in children with cancer. Pediatr Blood Cancer 2010; 54:947-51.
60. Nosari AM, Nador G, de Gasperi A, et al. Prospective monocentric study of non-tunnelled central venous catheter-related complications in hematological patients. Leuk Lymphoma 2008; 49:2148-55.
61. Anaissie E, Samonis G, Kontoyiannis D, et al. Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis 1995; 14:134-7.
62. Andrivet P, Bacquer A, Ngoc CV, et al. Lack of clinical benefit from subcutaneous tunnel insertion of central venous catheters in immunocompromised patients. Clin Infect Dis 1994; 18:199-206. (Pubitemid 24055259)
63. Bakker J, van Overhagen H, Wielenga J, et al. Infectious complications of radiologically inserted Hickman catheters in patients with hematologic disorders. Cardiovasc Intervent Radiol 1998; 21:116-21. (Pubitemid 28144878)
64. Bock SN, Lee RE, Fisher B, et al. A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheterrelated sepsis in patients treated with immunotherapy. J Clin Oncol 1990; 8:161-9. (Pubitemid 20032460)
65. Bouza E, Alvarado N, Alcala L, Perez MJ, Rincon C, Munoz P. A randomized and prospective study of 3 procedures for the diagnosis of catheter-related bloodstream infection without catheter withdrawal. Clin Infect Dis 2007; 44:820-6. (Pubitemid 46365307)
66. Bouza E, Munoz P, Lopez-Rodriguez J, et al. A needleless closed system device (CLAVE) protects from intravascular catheter tip and hub colonization: a prospective randomized study. J Hosp Infect 2003; 54:279-87. (Pubitemid 37554923)
67. Butt T, Afzal RK, Ahmad RN, Hussain I, Anwar M. Central venous catheter-related bloodstream infections in cancer patients. J Coll Physicians Surg Pak 2004; 14:549-52. (Pubitemid 39341730)
68. Carbon RT, Lugauer S, Geitner U, et al. Reducing catheter-associated infections with silver-impregnated catheters in long-term therapy of children. Infection 1999; 27(Suppl 1):S69-73. (Pubitemid 29255581)
69. Goey SH, Verweij J, Bolhuis RL, et al. Tunnelled central venous catheters yield a low incidence of septicaemia in interleukin-2-treated patients. Cancer Immunol Immunother 1997; 44:301-4. (Pubitemid 27307056)
70. Koldehoff M, Zakrzewski JL. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents 2004; 24:491-5. (Pubitemid 39425163)
71. Liaw CC, Chen JS, Chang HK, Huang JS, Yang TS, Liau CT. Symptoms and signs of port-related infections in oncology patients related to the offending pathogens. Int J Clin Pract 2008; 62:1193-8.
72. Uderzo C, D'Angelo P, Rizzari C, et al. Central venous catheter-related complications after bone marrow transplantation in children with hematological malignancies. Bone Marrow Transplant 1992; 9:113-7.
73. Abdelkefi A, Achour W, Ben Othman T, et al. Difference in time to positivity is useful for the diagnosis of catheter-related bloodstream infection in hematopoietic stem cell transplant recipients. BoneMarrow Transplant 2005; 35:397-401. (Pubitemid 40309486)
74. Jaeger K, Osthaus A, Heine J, et al. Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent catheterassociated infection in cancer patients. Chemotherapy 2001; 47:50-5. (Pubitemid 32008934)
75. Jaeger K, Zenz S, Juttner B, et al. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. Ann Hematol 2005; 84:258-62. (Pubitemid 40425073)
76. Ostendorf T, Meinhold A, Harter C, et al. Chlorhexidine and silversulfadiazine coated central venous catheters in haematological patients-A double-blind, randomised, prospective, controlled trial. Support Care Cancer 2005; 13:993-1000. (Pubitemid 41636007)
77. Forchielli ML, Lo CW, Richardson D, Gura K, Walker WA, Tonelli E. Central venous line related bacteremia during total parenteral nutrition and/or chemotherapy infusions in children. Ann Ig 1997; 9:35-40.
78. Raad I, Narro J, Khan A, Tarrand J, Vartivarian S, Bodey GP. Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis 1992; 11: 675-82.
79. Malgrange VB, Escande MC, Theobald S. Validity of earlier positivity of central venous blood cultures in comparison with peripheral blood cultures for diagnosing catheter-related bacteremia in cancer patients. J Clin Microbiol 2001; 39:274-8. (Pubitemid 32059603)
80. Cesaro S, Corro R, Pelosin A, et al. A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol 2004; 83:183-8. (Pubitemid 38292240)
81. Chaftari AM, Hachem R, Mulanovich V, et al. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents 2010; 36:182-6.
82. Franklin JA, Gaur AH, Shenep JL, Hu XJ, Flynn PM. In situ diagnosis of central venous catheter-related bloodstream infection without peripheral blood culture. Pediatr Infect Dis J 2004; 23:614-8. (Pubitemid 38924884)
83. Gaur AH, Flynn PM, Giannini MA, Shenep JL, Hayden RT. Difference in time to detection: a simple method to differentiate catheter-related from non-catheter-related bloodstream infection in immunocompromised pediatric patients. Clin Infect Dis 2003; 37:469-75. (Pubitemid 37011768)
84. Gaur AH, Flynn PM, Heine DJ, Giannini MA, Shenep JL, Hayden RT. Diagnosis of catheter-related bloodstream infections among pediatric oncology patients lacking a peripheral culture, using differential time to detection. Pediatr Infect Dis J 2005; 24:445-9. (Pubitemid 40664241)
85. Abdelkefi A, Achour W, Othman TB, et al. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection. J Support Oncol 2007; 5:273-8. (Pubitemid 46995362)
86. Abdelkefi A, Achour W, Torjman L, et al. Detection of catheterrelated bloodstream infections by the Gram stain-acridine orange leukocyte cytospin test in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2006; 37:595-9. (Pubitemid 43378833)
87. Abdelkefi A, Othman TB, Kammoun L, et al. Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial. Thromb Haemost 2004; 92:654-61. (Pubitemid 39248024)
88. Fratino G, Molinari AC, Parodi S, et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol 2005; 16:648-54. (Pubitemid 40613333)
89. Penel N, Neu JC, Clisant S, Hoppe H, Devos P, Yazdanpanah Y. Risk factors for early catheter-related infections in cancer patients. Cancer 2007; 110:1586-92. (Pubitemid 47463074)
90. Viale P, Pagani L, Petrosillo N, et al. Antibiotic lock-technique for the treatment of catheter-related bloodstream infections. J Chemother 2003; 15:152-6. (Pubitemid 36609752)
91. Abdelkefi A, Torjman L, Ladeb S, et al. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease. J Clin Oncol 2005; 23:7864-70. (Pubitemid 46657384)
92. Slobbe L, Doorduijn JK, Lugtenburg PJ, et al. Prevention of catheterrelated bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One 2010; 5:e10840.
93. Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004; 140:18-25.
94. Barbaric D, Curtin J, Pearson L, Shaw PJ. Role of hydrochloric acid in the treatment of central venous catheter infections in children with cancer. Cancer 2004; 101:1866-72. (Pubitemid 39314751)
95. Cesaro S, Tridello G, Cavaliere M, et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. J Clin Oncol 2009; 27:2059-65.
96. Dannenberg C, Bierbach U, Rothe A, Beer J, Korholz D. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with Broviac catheter. J Pediatr Hematol Oncol 2003; 25:616-21. (Pubitemid 36959422)
97. Early TF, Gregory RT, Wheeler JR, Snyder SO Jr, Gayle RG. Increased infection rate in double-lumen versus single-lumen Hickman catheters in cancer patients. South Med J 1990; 83:34-6. (Pubitemid 20049620)
98. Lim SH, Smith MP, Machin SJ, Goldstone AH. Prophylactic teicoplanin during insertion of Hickman catheters. Br J Haematol 1990; 76(Suppl 2):27-9.
99. Lim SH, Smith MP, Machin SJ, Goldstone AH. Teicoplanin and prophylaxis of Hickman catheter insertions. Eur J Surg Suppl 1992: 39-42.
100. Lim SH, Smith MP, Machin SJ, Goldstone AH. A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies. Eur J Haematol Suppl 1993; 54:10-3. (Pubitemid 23224527)
101. Lim SH, Smith MP, Salooja N, Machin SJ, Goldstone AH. A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies. J Antimicrob Chemother 1991; 28:109-16.
102. Vassilomanolakis M, Plataniotis G, Koumakis G, et al. Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-coursevancomycin prophylaxis. Bone Marrow Transplant 1995; 15:77-80.
103. Vlasveld LT, Rodenhuis S, Rutgers EJ, et al. Catheter-related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheter. Eur J Surg Oncol 1994; 20:122-9. (Pubitemid 24164465)
104. Nieboer P, de Vries EG, Mulder NH, et al. Factors influencing catheterrelated infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients. Bone Marrow Transplant 2008; 42:475-81.
105. Ozyuvaci E, Kutlu F. Totally implantable venous access devices via subclavian vein: a retrospective study of 368 oncology patients. Adv Ther 2006; 23:574-81. (Pubitemid 44747438)
106. Abbas AA, Fryer CJ, Paltiel C, et al. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatr Blood Cancer 2004; 42:325-31. (Pubitemid 38327625)
107. DesJardin JA, Falagas ME, Ruthazer R, et al. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med 1999; 131:641-7. (Pubitemid 29517948)
108. Goldschmidt H, Hahn U, Salwender HJ, et al. Prevention of catheterrelated infections by silver coated central venous catheters in oncological patients. Zentralbl Bakteriol 1995; 283:215-23.
109. Gorelick MH, Owen WC, Seibel NL, Reaman GH. Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients. Pediatr Infect Dis J 1991; 10:506-10.
110. Harter C, Salwender HJ, Bach A, Egerer G, Goldschmidt H, Ho AD. Catheter-related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy: a prospective comparison of silver-coated and uncoated catheters. Cancer 2002; 94:245-51. (Pubitemid 34049065)
111. Hartmann LC, Urba WJ, Steis RG, et al. Use of prophylactic antibiotics for prevention of intravascular catheter-related infections in interleukin-2-treated patients. J Natl Cancer Inst 1989; 81:1190-3. (Pubitemid 19197079)
112. Lee SH, Hahn ST. Comparison of complications between transjugular and axillosubclavian approach for placement of tunneled, central venous catheters in patients with hematological malignancy: a prospective study. Eur Radiol 2005; 15:1100-4. (Pubitemid 40778730)
113. Rackoff WR, Weiman M, Jakobowski D, et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr 1995; 127:147-51.
114. Raucher HS, Hyatt AC, Barzilai A, et al. Quantitative blood cultures in the evaluation of septicemia in children with Broviac catheters. J Pediatr 1984; 104:29-33. (Pubitemid 14178456)
115. Sanchez-Munoz A, Aguado JM, Lopez-Martin A, et al. Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters. Eur J Clin Microbiol Infect Dis 2005; 24:291-3. (Pubitemid 40768502)
116. Vokurka S, Kabatova-Maxova K, Skardova J, Bystricka E. Antimicrobial chlorhexidine/silver sulfadiazine-coated central venous catheters versus those uncoated in patients undergoing allogeneic stem cell transplantation. Support Care Cancer 2009; 17:145-51.
117. Benezra D, Kiehn TE, Gold JW, Brown AE, Turnbull AD, Armstrong D. Prospective study of infections in indwelling central venous catheters using quantitative blood cultures. Am J Med 1988; 85: 495-8.
118. Douard MC, Arlet G, Leverger G, et al. Quantitative blood cultures for diagnosis and management of catheter-related sepsis in pediatric hematology and oncology patients. Intensive Care Med 1991; 17: 30-5.
119. Germanakis I, Christidou A, Galanakis E, Kyriakakis I, Tselentis Y, Kalmanti M. Qualitative versus quantitative blood cultures in the diagnosis of catheter-related bloodstream infections in children with malignancy. Pediatr Blood Cancer 2005; 45:939-44. (Pubitemid 41552163)
120. Germanakis J, Stiakaki E, Galanakis E, et al. Prognostic value of quantitative blood cultures for the outcome of central venous catheters in children. Scand J Infect Dis 2002; 34:680-2.
121. Ghanem GA, Boktour M, Warneke C, et al. Catheter-related Staphylococcus aureus bacteremia in cancer patients: high rate of complications with therapeutic implications. Medicine (Baltimore) 2007; 86:54-60. (Pubitemid 46104920)
122. Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections and thrombotic events in immu-nocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol 2000; 18:1269-78. (Pubitemid 30159845)
123. Logghe C, Van Ossel C, D'Hoore W, Ezzedine H, Wauters G, Haxhe JJ. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect 1997; 37:145-56. (Pubitemid 27472630)
124. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990; 8:1591-7. (Pubitemid 20301191)
125. Wurzel CL, Halom K, Feldman JG, Rubin LG. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child 1988; 142:536-40.
126. Elishoov H, Or R, Strauss N, Engelhard D. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study. Medicine (Baltimore) 1998; 77:83-101. (Pubitemid 28165031)
127. Engelhard D, Elishoov H, Strauss N, et al. Nosocomial coagulasenegative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study. Transplantation 1996; 61:430-4. (Pubitemid 26067920)
128. Daghistani D, Horn M, Rodriguez Z, Schoenike S, Toledano S. Prevention of indwelling central venous catheter sepsis. Med Pediatr Oncol 1996; 26:405-8. (Pubitemid 26131899)
129. Eastman ME, Khorsand M, Maki DG, et al. Central venous devicerelated infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2. Cancer 2001; 91:806-14. (Pubitemid 32173307)
130. Escudier B, Lethiec JL, Angevin E, et al. Totally implanted catheters to reduce catheter-related infections in patients receiving interleukin-2: a 2-year experience. Support Care Cancer 1995; 3:297-300.
131. Jones GR, Konsler GK, Dunaway RP, Lacey SR, Azizkhan RG. Prospective analysis of urokinase in the treatment of catheter sepsis in pediatric hematology-oncology patients. J Pediatr Surg 1993; 28:350-5.
132. Jones PM. Indwelling central venous catheter-related infections and two different procedures of catheter care. Cancer Nurs 1987; 10:123-30.
133. King DR, Komer M, Hoffman J, et al. Broviac catheter sepsis: the natural history of an iatrogenic infection. J Pediatr Surg 1985; 20:728-33. (Pubitemid 16175630)
134. Sanders J, Pithie A, Ganly P, et al. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother 2008; 62:809-15.
135. Shah SS, Downes KJ, Elliott MR, Bell LM, McGowan KL, Metlay JP. How long
136. Soo RA, Gosbell IB, Gallo JH, et al. Hickman catheter complications in a haematology unit, 1996-98. Intern Med J 2002; 32:100-3.
137. Dugdale DC, Ramsey PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 1990; 89:137-41. (Pubitemid 20254436)
138. Kelly C, Dumenko L, McGregor SE, McHutchion ME. A change in flushing protocols of central venous catheters. Oncol Nurs Forum 1992; 19:599-605.
139. Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO. Hickman catheter infections in patients with malignancies. Medicine (Baltimore) 1984; 63:189-200. (Pubitemid 14090665)
140. Solomon B, Moore J, Arthur C, Prince HM. Lack of efficacy of twiceweekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin. Eur J Cancer 2001; 37:2379-84. (Pubitemid 33097474)
141. Volkow P, Vazquez C, Tellez O, et al. Polyurethane II catheter as longindwelling intravenous catheter in patients with cancer. Am J Infect Control 2003; 31:392-6. (Pubitemid 37392960)
142. Astagneau P, Maugat S, Tran-Minh T, et al. Long-term central venous catheter infection in HIV-infected and cancer patients: a multicenter cohort study. Infect Control Hosp Epidemiol 1999; 20: 494-8.
143. Kim SH, Kang CI, Kim HB, et al. Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2003; 24:897-904.
144. Babu R, Turner A, Nicholls G, Spicer RD. Surgical risk factors for Hickman catheter sepsis: a prospective study. Pediatr Surg Int 2004; 20:369-71. (Pubitemid 38962903)
145. Carratala J, Niubo J, Fernandez-Sevilla A, et al. Randomized, doubleblind trial of an antibiotic-lock technique for prevention of Grampositive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999; 43:2200-4. (Pubitemid 29421200)
146. Das I, Philpott C, George RH. Central venous catheter-related septicaemia in paediatric cancer patients. J Hosp Infect 1997; 36:67-76. (Pubitemid 27235036)
147. Kappers-Klunne MC, Degener JE, Stijnen T, Abels J. Complications from long-term indwelling central venous catheters in hematologic patients with special reference to infection. Cancer 1989; 64:1747-52. (Pubitemid 19251150)
148. Kim DH, Bae NY, Sung WJ, et al. Hickman catheter site infections after allogeneic stem cell transplantation: a single-center experience. Transplant Proc 2004; 36:1569-73. (Pubitemid 38903032)
149. Lai CH, Wong WW, Chin C, et al. Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients. Clin Microbiol Infect 2006; 12:986-91. (Pubitemid 44322571)
150. Simon C, Suttorp M. Results of antibiotic treatment of Hickmancatheter-related infections in oncological patients. Support Care Cancer 1994; 2:66-70.
151. Biffi R, De Braud F, Orsi F, et al. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum followup of 180 days. Ann Oncol 1998; 9:767-73. (Pubitemid 28394164)
152. Biffi R, Martinelli G, Pozzi S, et al. Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device. Bone Marrow Transplant 1999; 24:89-93. (Pubitemid 29346611)
153. Groeger JS, Lucas AB, Coit D, et al. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg 1993; 218:206-10. (Pubitemid 23229149)
154. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993; 119:1168-74. (Pubitemid 23361446)
155. La Quaglia MP, Lucas A, Thaler HT, Friedlander-Klar H, Exelby PR, Groeger JS. A prospective analysis of vascular access device-related infections in children. J Pediatr Surg 1992; 27:840-2.
156. Biagi E, Arrigo C, Dell'Orto MG, et al. Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies. Support Care Cancer 1997; 5:228-33. (Pubitemid 27212873)
157. Castagnola E, Molinari AC, Giacchino M, et al. Incidence of catheterrelated infections within 30 days from insertion of Hickman-Broviac catheters. Pediatr Blood Cancer 2007; 48:35-8. (Pubitemid 44871590)
158. Chee L, Brown M, Sasadeusz J, MacGregor L, Grigg AP. Gramnegative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies. J Infect 2008; 56:227-33.
159. Coyle VM, McMullan R, Morris TC, Rooney PJ, Hedderwick S. Catheter-related bloodstream infection in adult haematology patients: catheter removal practice and outcome. J Hosp Infect 2004; 57:325-31. (Pubitemid 39023362)
160. Guiot HF, Helmig-Schurter AV, van 't Noordende JM. The relevance of cultures of catheter-drawn blood and heparin-lock fluid to diagnose infection in hematologic patients. Ann Hematol 1992; 64:28-34.
161. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296:1305-9. (Pubitemid 8103695)
162. Hanna H, Benjamin R, Chatzinikolaou I, et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 2004; 22:3163-71. (Pubitemid 41103731)
163. Hanna HA, Raad I. Blood products: a significant risk factor for longterm catheter-related bloodstream infections in cancer patients. Infect Control Hosp Epidemiol 2001; 22:165-6. (Pubitemid 32233896)
164. Huang WT, Chen TY, Su WC, Yen CJ, Tsao CJ. Implantable venous port-related infections in cancer patients. Support Care Cancer 2004; 12:197-201.
165. Koolen DA, van Laarhoven HW, Wobbes T, Punt CJ. Single-centre experience with tunnelled central venous catheters in 150 cancer patients. Neth J Med 2002; 60:397-401. (Pubitemid 39089357)
166. Handrup MM, Moller JK, Frydenberg M, Schroder H. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2010; 55:309-13.
167. Park KH, Cho OH, Lee SO, et al. Outcome of attempted Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia. Ann Hematol 2010; 89:1163-9.
168. Pegues D, Axelrod P, McClarren C, et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 1992; 49:156-62.
169. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15:231-8.
170. Rao JS, O'Meara A, Harvey T, Breatnach F. A new approach to the management of Broviac catheter infection. JHosp Infect 1992; 22:109-16.
171. Seifert H, Cornely O, Seggewiss K, et al. Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresis. J Clin Microbiol 2003; 41:118-23. (Pubitemid 36098564)
172. van Rooden CJ, Schippers EF, Guiot HF, et al. Prevention of coagulasenegative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies. J Clin Oncol 2008; 26:428-33. (Pubitemid 351171695)
173. Viscoli C, Castagnola E, Giacchino M, et al. Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian association of paediatric haematology and oncology. Supportive therapy Group-infectious diseases Section. Eur J Cancer 1999; 35: 770-4. (Pubitemid 29258146)
174. Addeo A, Tonda L, Sirgiovanni MP, Giacoletti G, Citro R, Ramus GV. Complication rates in the clinical practice of long-term use central venous catheters in cancer patients. Eur J Oncol 2009; 14:27-31.
175. Andremont A, Paulet R, Nitenberg G, Hill C. Value of semiquantitative cultures of blood drawn through catheter hubs for estimating the risk of catheter tip colonization in cancer patients. J Clin Microbiol 1988; 26:2297-9.
176. Aquino VM, Sandler ES, Mustafa MM, Steele JW, Buchanan GR. A prospective double-blind randomized trial of urokinase flushes to prevent bacteremia resulting from luminal colonization of subcutaneous central venous catheters. J Pediatr Hematol Oncol 2002; 24:710-3. (Pubitemid 35448733)
177. Arul GS, Lewis N, Bromley P, Bennett J. Ultrasound-guided percutaneous insertion of Hickman lines in children. Prospective study of 500 consecutive procedures. J Pediatr Surg 2009; 44:1371-6.
178. Averbuch D, Makhoul R, Rotshild V, Weintraub M, Engelhard D. Empiric treatment with once-daily cefonicid and gentamicin for febrile non-neutropenic pediatric cancer patients with indwelling central venous catheters. J Pediatr Hematol Oncol 2008; 30:527-32.
179. Barriga FJ, Varas M, Potin M, et al. Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Med Pediatr Oncol 1997; 28:196-200. (Pubitemid 27078422)
180. Benhamou E, Fessard E, Com-Nougue C, et al. Less frequent catheter dressing changes decrease local cutaneous toxicity of high-dose chemotherapy in children, without increasing the rate of catheter-related infections: results of a randomised trial. Bone Marrow Transplant 2002; 29:653-8. (Pubitemid 34591307)
181. Biffi R, Orsi F, Pozzi S, et al. Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial. Ann Oncol 2009; 20:935-40.
182. Castagnola E, Fratino G, Valera M, Giacchino M, Haupt R, Molinari AC. Correlation between "malfunctioning events" and catheterrelated infections in pediatric cancer patients bearing tunneled indwelling central venous catheter: results of a prospective observational study. Support Care Cancer 2005; 13:757-9. (Pubitemid 41435568)
183. Chatzinikolaou I, Hanna H, Graviss L, et al. Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance. Infect Control Hosp Epidemiol 2003; 24:961-3. (Pubitemid 38029566)
184. Cheong K, Perry D, Karapetis C, Koczwara B. High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours. Intern Med J 2004; 34:234-8. (Pubitemid 38757078)
185. Edwards DP, Brookstein R. Hickman lines inserted and managed by a general surgical team: Longevity and complications. Br J Clin Pract 1997; 51:47-8.
186. Elihu A, Gollin G. Complications of implanted central venous catheters in neutropenic children. Am Surg 2007; 73:1079-82. (Pubitemid 351396572)
187. Haimi-Cohen Y, Husain N, Meenan J, Karayalcin G, Lehrer M, Rubin LG. Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: Simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique. Antimicrob Agents Chemother 2001; 45:1565-7. (Pubitemid 32374137)
188. Harms D, Gortitz I, Lambrecht W, Kabisch H, Erttmann R, Janka-Schaub G. Infectious risks of Broviac catheters in children with neoplastic diseases: a matched pairs analysis. Pediatr Infect Dis J 1992; 11:1014-8.
189. Hemsworth S, Selwood K, van Saene R, Pizer B. Does the number of exogenous infections increase in paediatric oncology patients when sterile surgical gloves are not worn for accessing central venous access devices? Eur J Oncol Nurs 2007; 11:442-7.
190. Hengartner H, Berger C, Nadal D, Niggli FK, Grotzer MA. Port-A-Cath infections in children with cancer. Eur J Cancer 2004; 40: 2452-8. (Pubitemid 39424960)
191. Henneberg SW, Jungersen D, Hole P. Durability of central venous catheters. A randomized trial in children with malignant diseases. Paediatr Anaesth 1996; 6:449-51. (Pubitemid 126440428)
192. Jones PG, Hopfer RL, Elting L. Semiquantitative cultures of intravascular catheters from cancer patients. Diagn Microbiol Infect Dis 1986; 4:299-306. (Pubitemid 16036577)
193. Krog MP, Ekbom A, Nystrom-Rosander C. Central venous catheters in acute blood malignancies. Cancer 1987; 59:1358-61. (Pubitemid 17035484)
194. La Quaglia MP, Caldwell C, Lucas A, et al. A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children. J Pediatr Surg 1994; 29:742-5. (Pubitemid 24191353)
195. Laurenzi L, Natoli S, Benedetti C, et al. Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices. Support Care Cancer 2004; 12:805-9. (Pubitemid 40064264)
196. Ley BE, Jalil N, McIntosh J, et al. Bolus or infusion teicoplanin for intravascular catheter associated infections in immunocompromised patients? J Antimicrob Chemother 1996; 38:1091-5. (Pubitemid 27073291)
197. Ljungman P, Hagglund H, Bjorkstrand B, Lonnqvist B, Ringden O. Perroperative teicoplanin for prevention of Gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study. Support Care Cancer 1997; 5:485-8. (Pubitemid 27494875)
198. Matsuzaki A, Suminoe A, Koga Y, Hatano M, Hattori S, Hara T. Longterm use of peripherally inserted central venous catheters for cancer chemotherapy in children. Support Care Cancer 2006; 14:153-60. (Pubitemid 43119611)
199. Nam SH, Kim DY, Kim SC, Kim IK. Complications and risk factors of infection in pediatric hemato-oncology patients with totally implantable access ports (TIAPs). Pediatr Blood Cancer 2010; 54:546-51.
200. Nouwen JL, van Belkum A, de Marie S, et al. Clonal expansion of Staphylococcus epidermidis strains causing Hickman catheter-related infections in a hemato-oncologic department. J Clin Microbiol 1998; 36:2696-702. (Pubitemid 28380979)
201. Olson TA, Fischer GW, Lupo MC, et al. Antimicrobial therapy of Broviac catheter infections in pediatric hematology oncology patients. J Pediatr Surg 1987; 22:839-42. (Pubitemid 17149314)
202. Pedersen G, NorgaardM, KiiveriM, et al. Risk of bacteremia in patients with hematological and other malignancies after initial placement of a central venous catheter. J Long TermEff Med Implants 2007; 17:303-11.
203. Rackoff WR, Ge J, Sather HN, Cooper HA, Hutchinson RJ, Lange BJ. Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol 1999; 21:260-7. (Pubitemid 30316853)
204. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990; 15:95-102. (Pubitemid 20123908)
205. Rasero L, Degl'Innocenti M, Mocali M, et al. Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. Haematologica 2000; 85:275-9. (Pubitemid 30340144)
206. Rizzari C, Palamone G, Corbetta A, Uderzo C, Vigano EF, Codecasa G. Central venous catheter-related infections in pediatric hematologyoncology patients: role of home and hospital management. Pediatr Hematol Oncol 1992; 9:115-23.
207. Samaras P, Dold S, Braun J, et al. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients. Oncology 2008; 74:237-44.
208. Scheinemann K, Ethier MC, Dupuis LL, et al. Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line. Support Care Cancer 2010; 18:913-9.
209. Schwarz RE, Groeger JS, Coit DG. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 1997; 79:1635-40. (Pubitemid 27154800)
210. Stoiser B, Kofler J, Staudinger T, et al. Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters. J Hosp Infect 2002; 50:202-6. (Pubitemid 37554875)
211. Strahilevitz J, Lossos IS, Verstandig A, Sasson T, Kori Y, Gillis S. Vascular access via peripherally inserted central venous catheters (PICCs): experience in 40 patients with acute myeloid leukemia at a single institute. Leuk Lymphoma 2001; 40:365-71. (Pubitemid 32401393)
212. Walshe LJ, Malak SF, Eagan J, Sepkowitz KA. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol 2002; 20:3276-81. (Pubitemid 34831526)
213. Wylie MC, Graham DA, Potter-Bynoe G, et al. Risk factors for central line-associated bloodstream infection in pediatric intensive care units. Infect Control Hosp Epidemiol 2010; 31:1049-56.
214. Powers RJ, Wirtschafter DW. Decreasing central line associated bloodstream infection in neonatal intensive care. Clin Perinatol 2010; 37:247-72.
215. Li S, Bizzarro MJ. Prevention of central line associated bloodstream infections in critical care units. Curr Opin Pediatr 2011; 23: 85-90.
216. Blot F, Nitenberg G, Brun-Buisson C. New tools in diagnosing catheterrelated infections. Support Care Cancer 2000; 8:287-92. (Pubitemid 30430051)
217. Guembe M, Rodriguez-Creixems M, Sanchez-Carrillo C, Perez-Parra A, Martin-Rabadan P, Bouza E. How many lumens should be cultured in the conservative diagnosis of catheter-related bloodstream infections? Clin Infect Dis 2010; 50:1575-9.
218. Randolph AG, Brun-Buisson C, Goldmann D. Identification of central venous catheter-related infections in infants and children. Pediatr Crit Care Med 2005; 6(Suppl 3):S19-24. (Pubitemid 40724247)